semaglutide news today The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added Type 2 diabetes: New Ozempic
Description
[DOI] [PubMed] [Google Scholar] Wang Y, Lomakin A, Kanai S, Alex R, Benedek GB
Aten Primaria
The mechanism that causes false positives for ibuprofen (cyclooxygenase inhibitor with ketone-containing ring structure) or pseudoephedrine (phenethylamine derivative) simply has no analog in semaglutide biochemistry
GLP-1RA medications have been suggested to increase the risk of other malignancies such as thyroid cancer
"Notice: Multiple Additions to the Prescription Drug List (PDL) [2023-03-08]"
These lifestyle measures not only support the weight loss achieved with retatrutide but also contribute to long-term weight maintenance, which remains a challenge following any pharmacological intervention
